Editing Prostate Cancer: Diagnosis and evaluation (section)

====== Guidelines on Use of MRI Before Biopsy ======

* '''2023 AUA Guidelines on Early Detection of Prostate Cancer'''
**'''<span style="color:#ff0000">May be used prior to initial biopsy to increase the detection of GG2+ prostate cancer[https://pubmed.ncbi.nlm.nih.gov/23659877/]</span>'''
***It is reasonable to obtain an mpMRI in biopsy-naïve patients prior to their first biopsy, but such a practice cannot be regarded as the standard approach based on the currently available evidence. 
*'''2023 NCCN (PROSD-3)'''
**'''Multiparametric MRI is strongly recommended, if available'''
*'''2022 EAU[https://uroweb.org/guidelines/prostate-cancer/chapter/diagnostic-evaluation]'''
**'''Systematic biopsy is an acceptable approach in case MRI is unavailable''' 
*2017 Cancer Care Ontario Guidelines
** '''<span style="color:#ff0000">Biopsy-naïve: MRI should not be considered standard of care'''
** '''<span style="color:#ff0000">Prior negative biopsy: MRI followed by targeted biopsy may be considered</span>'''